Latest autoimmune disease Stories
NEW YORK and ANN ARBOR, Mich., March 25, 2015 /PRNewswire/ -- Lycera Corp., a biopharmaceutical company developing breakthrough medicines to treat cancer and autoimmune disease, today announced
The Robbles share their experiences with God in the midst of a chronic illness Arvada, CO (PRWEB) March 16, 2015 Michael and Margaret Robble’s new
-BRIGHT-SC study passes futility analysis and will continue to completion HAYWARD, Calif., March 16, 2015 /PRNewswire/ -- Anthera Pharmaceuticals, Inc.
A joint statement of more than 30 researchers and physicians is a “watershed moment” for this syndrome that affects 1 in 200 children in the United States. Menlo
Researchmoz.us announces that a new market research report is available in its catalogue: Celiac Disease - Opportunity Analysis and Forecast to 2023 Albany,
Weidert Group has been selected as the inbound marketing partner for immunoLink™ Therapies, an immunotherapy company focused on helping patients achieve balanced health from strong immune systems
NEW YORK and ANN ARBOR, Mich., Feb.
ANN ARBOR, Mich., Feb.
NEW YORK, Jan. 12, 2015 /PRNewswire/ -- Conatus Pharmaceuticals Inc.
- To play, gamble.
- To impose upon; delude; trick; humbug; also, to joke; chaff.
- A deceitful game or trick; trickery; humbug; nonsense.